Fig. 8 Schematic view of the NGFR/LCN2/SLC22A17-dependent neurogenic switch mechanism in astroglia.
Nerve growth factor receptor can convert reactive astroglia to neurogenic state in mouse model of Alzheimer’s disease (AD) through suppression of Lcn2 activity on Slc22a17 receptor. In AD cohorts in humans,